CABA Cabaletta Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CABA

Price (delayed)

$2.22

Market cap

$376.39M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.52

Enterprise value

$177M

?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 22
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2
Highlights
The equity has soared by 104% from the previous quarter and by 18% YoY
Cabaletta Bio's quick ratio has surged by 101% QoQ and by 20% YoY
CABA's debt is up by 3.3% year-on-year but it is down by 2.8% since the previous quarter
CABA's net income is down by 26% year-on-year and by 3.4% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.cabalettabio.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of CABA

CABA stock price

How has the Cabaletta Bio stock price performed over time
Intraday
-11.2%
1 week
-10.84%
1 month
-29.07%
1 year
-8.26%
YTD
1.37%
QTD
-28.62%

Financial performance

How have Cabaletta Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$185.52M
Net income
-$181.32M
Gross margin
N/A
Net margin
N/A
CABA's net income is down by 26% year-on-year and by 3.4% since the previous quarter
The operating income has contracted by 24% YoY and by 3.4% from the previous quarter

Price vs fundamentals

How does CABA's price correlate with its fundamentals

Growth

What is Cabaletta Bio's growth rate over time

Valuation

What is Cabaletta Bio stock price valuation
P/E
N/A
P/B
1.72
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
CABA's EPS is up by 44% YoY and by 20% QoQ
The equity has soared by 104% from the previous quarter and by 18% YoY
CABA's price to book (P/B) is 12% lower than its last 4 quarters average of 2.2 but 2.1% higher than its 5-year quarterly average of 1.9

Efficiency

How efficient is Cabaletta Bio business performance
Cabaletta Bio's ROE has decreased by 39% YoY but it has increased by 2.5% from the previous quarter
Cabaletta Bio's return on assets has decreased by 29% YoY
The ROIC has contracted by 26% from the previous quarter but it has grown by 22% YoY

Dividends

What is CABA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CABA.

Financial health

How did Cabaletta Bio financials performed over time
Cabaletta Bio's quick ratio has surged by 101% QoQ and by 20% YoY
The current ratio has soared by 96% from the previous quarter and by 21% YoY
CABA's debt is 88% smaller than its equity
The equity has soared by 104% from the previous quarter and by 18% YoY
Cabaletta Bio's debt to equity has plunged by 54% from the previous quarter and by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.